Clear Search

AMA Center for Health Equity

UPDATED
·
4 MIN READ

AMA’s Center for Health Equity mission and guiding principles

Learn about the AMA’s Center for Health Equity mission and guiding principles for embedding health equity within the association and the medical profession.
Narcan nasal spray

Overdose Epidemic

·
4 MIN READ

Narcan lands OTC approval: What it means for patients, doctors

The drug’s manufacturer and retailers must help ensure the lifesaving opioid overdose-reversal medication is widely available at an affordable price. 

Press Releases

·
1 MIN READ

AMA statement on DEA extending telehealth prescription flexibilities

The AMA applauds the DEA extending flexibilities in the prescribing of controlled substances through telehealth visits through Nov. 11, 2023.

Person looking at a laptop while writing

Overdose Epidemic

·
3 MIN READ

Here’s your one-stop shop to meet new DEA training mandate

DEA-registered physicians are required to complete the one time, eight-hour training requirement. The AMA has you covered. Learn more.

Overdose Epidemic

·
12 MIN READ

Naloxone: FDA approves over-the-counter Narcan nasal spray with Bobby Mukkamala, MD

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Narcan, the over-the-counter naloxone nasal spray, and more.

Overdose Epidemic

·
12 MIN READ

Naloxone: FDA approves over-the-counter Narcan nasal spray with Bobby Mukkamala, MD [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Narcan, the over-the-counter naloxone nasal spray, and more.

Press Releases

·
3 MIN READ

AMA launches resource to help physicians meet DEA training requirement

The AMA Ed Hub™ has a new educational webpage for physicians to complete required training on treating patients with opioid or other substance use disorders.

Rahul Gupta, MD, speaking at the 2023 National Advocacy Conference

Overdose Epidemic

·
5 MIN READ

Every 5 minutes a person dies of drug overdose. This must end.

Rahul Gupta, MD, MPH, is the first physician to direct the White House’s drug-control policy. Learn why he says treatment is key to the strategy.

Advocacy Update

·
13 MIN READ

Feb. 24, 2023: National Advocacy Update

FDA advisory panels vote 19-0 in favor of OTC naloxone and more in the latest National Advocacy Update.

Your powerful ally

The AMA helps physicians build a better future for medicine, advocating in the courts and on the Hill to remove obstacles to patient care and confront today’s greatest health crises. 

Half-price dues: Limited time offer. Learn more!

Join the AMA